A2/A2B to B renal transplantation: Past, present, and future directions

American Journal of Transplantation

Volumn 16, Issue 1, 2016, Pages 11-20

  Bryan, C F ^a   Cherikh, W S ^b   Sesok Pizzini, D A ^c  

^a Midwest Transplant Network   (United States)

^b UNITED NETWORK FOR ORGAN SHARING   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP ABO SYSTEM;

ANTIBODY TITER; ANTIGEN EXPRESSION; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP B; BLOOD GROUP O; BLOOD TRANSFUSION; DISEASE COURSE; FOLLOW UP; HUMAN; HUMORAL IMMUNE DEFICIENCY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; DONOR; IMMUNOLOGY; RESOURCE ALLOCATION; TRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; HUMANS; KIDNEY TRANSPLANTATION; RESOURCE ALLOCATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84956920982     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13499     Document Type: Review

References (39)

1. Bryan CF, Cherikh WS, Debroy MA, et al., Increased access for blood group B candidates in the U.S. after a policy change to not allocate B kidneys to AB candidates. Am J Transplant 2014; S3: 73.
2. Stegall MD, Dean PG, Gloor JM., ABO-incompatible kidney transplantation. Transplantation 2004; 78: 635-641.
3. Young CJ, Kew C., Health disparities in transplantation: Focus on the complexity and challenge of renal transplantation in African Americans. Med Clin N Am 2005; 89: 1003-1031.
4. Epstein AM, Ayanian JZ, Keogh JH, et al., Racial disparities in access to renal transplantation. N Engl J Med 2000; 343: 1537-1544.
5. Gaston RS., Addressing minority issues in renal transplantation: Is more equitable access an achievable goal ? Am J Transplant 2002; 2: 1-3.
6. Brynger H, Rydberg L, Samuelsson B, et al., Renal transplantation across a blood group barrier A2 kidneys to O recipients. Proc EDTA 1982; 19: 427-431.
7. Brynger H, Rydberg L, Samuelsson B, et al., Experience with 14 renal transplants with kidneys from blood group A (A2) to O recipients. Trans Proc 1984; 16: 1175-1176.
8. Breimer ME, Brynger H, Rydberg L, et al., Transplantation of blood group A2 kidneys to O recipients. Biochemical and immunological studies of blood group A antigens in human kidneys. Trans Proc 1985; 17: 2640-2643.
9. Breimer M, Brynger H, Rydberg L, et al., Blood group ABO incompatible kidney transplantation biochemical and immunochemical studies of blood group A glycolipid antigens in human kidney and characterization of the antibody response in O recipients receiving A2 grafts. Trans Proc 1987; 19: 226-230.
10. Visetti M, Leigheb G, Schudeller G, et al., Importance of subgroups A1-A2 for the survival of skin allografts. Minerva Dermatol 1967; 42: 563-569.
11. Nelson PW, Helling TS, Shield CF, et al., Current experience with renal transplantation across the ABO barrier. Am J Surg 1992; 164: 541-545.
12. Alkhunaizi AM, De Mattos AM, Barry JM, et al., Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999; 67: 1319-1324.
13. Bryan CF, Shield CF, Nelson PW, et al., Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. Transplantation 1998; 66: 1714-1717.
14. Nelson PW, Shield CF, Muruve NA, et al., Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: Time for a new national system ? Am J Transplant 2002; 2: 94-99.
15. Bryan CF, Winklhofer FT, Murillo D, et al., Improving access to kidney transplantation without decreasing graft survival: Long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation 2005; 80: 73-78.
16. Nelson PW, Hughes TM, Beck ML, et al., Stratification and successful transplantation of patients awaiting ABO-incompatible (A2 into B and O) transplantation by A-isoagglutinin-titer phenogroup. Transplant Proc 1996; 28: 221-223.
17. Williams WW, Cherikh WS, Young CJ, et al., First report on the OPTN national variance: Allocation of A2/A2B deceased donor kidneys to blood group B increases minority transplantation. Am J Transplant May 2015; doi: 10.1111/ajt.13409.
18. Breimer ME, Molne J, Norden G, et al., Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis and secretor status. Transplantation 2006; 82: 479-485.
19. Holgersson J, Rydberg L, Breimer ME., Molecular deciphering of the ABO system as a basis for novel diagnostics and therapeutics in ABO incompatible transplantation. Int Rev Immunol 2014; 1-21.
20. Skogsberg U, Brimer ME, Friman S, et al., Adult ABO incompatible liver transplantation using A2 and B donors. Xenotransplant 2006; 12: 154-159.
21. Fishbein TM, Emre S, Guy SR, et al., Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation 1999; 67: 1071-1073.
22. Kluger MD, Guarrera JV, Olsen SK, et al., Safety of blood group A2 to O liver transplantation: An analysis of the UNOS database. Transplantation 2012; 94: 526-531.
23. Bryan CF, Abdulkarim B, Nawabi A, et al., Blood group A isoagglutinins in A2 → O simultaneous liver/kidney transplantation may not influence kidney function. Am J Transplant 2011; 11: 1527-1530.
24. Bryan CF, Polesky H, Eisenbrey AB, et al., Implications of ABO error rates in proficiency testing for solid organ transplantation. Transplantation 2006; 6: 733-736.
25. Brecher ME, editor. AABB technical manual, 14th edition. Bethesda, MD: American Association of Blood Banks; 2002.
26. Bryan CF, McDonald SB, Harrell KM, et al., A method comparison for performing the anti-A titer assay for transplantation of A2 kidneys into B and O patients. Transplantation 2000; 69: S133.
27. Gloor JM, Lager DJ, Moore SB, et al., ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971-977.
28. AuBuchon JP, de Wildt-Eggen J, Dumont LJ., Reducing the variation in performance of antibody titrations. Arch Pathol Lab Med 2008; 132: 1194-1201.
29. Kumlein G, Wilpert J, Safwenberg J, et al., Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007; 84: S17-S19.
30. Bentall A, Regan F, White J, et al., No progress in ABO titer measurement: time to aim for a reference ? Transplantation 2014; 97: e19-e20.
31. Jeyakanthan M, Tao K, Zou L, et al., Chemical basis for qualitative and quantitative differences between ABO blood groups and subgroups: Implications for organ transplantation. Am J Transplant 2015. doi: 10.1111/ajt.13328
32. Hurst FP, Sajjad I, Elster EA, et al., Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience. Transplantation 2010; 89: 1396-1402.
33. Hanto DW, Brunt EM, Goss JA, et al., Accelerated acute rejection of an A2 renal allograft in an O recipient: Association with an increase in Anti-A2 antibodies. Transplantation 1993; 56: 1580-1583.
34. Yoo S, Lee EY, Huh KH, et al., Role of plasma exchange in ABO-incompatible kidney transplantation. Ann Lab Med 2012; 32: 283-288.
35. Sorensen JB, Grant WJ, Belnap LP, et al., Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant 2001; 1: 296-299.
36. Bryan CF, Nelson PW, Shield CF, et al., Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. Am J Transplant 2007; 7: 1181-1184.
37. Tierney J, Shaffer D., Transplantation of ABO A2 kidneys into O recipients: Do IgM anti-A1 titers matter ? Clin Transplant 2015. doi: 10.1111/ctr.12527
38. Osoria AV, Sullivan EK, Alexander SR, et al., ABO-mismatached renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and Midwest Organ Bank. Pediatr Transplant 1998; 2: 26-29.
39. Tazawa H, Irei T, Tanaka Y, et al., Blockade of invariant TCR-C1d interaction specifically inhibits antibody production against blood group A carbohydrates. Blood 2013; 122: 2582-2590.